Source: OINDPnews

Intertek: Intertek and CrystecPharma partner on DPI development services

Intertek, which provides a wide range of testing services for OINDPs, has announced a new partnership with particle engineering specialist CrystecPharma for creation of a "fast to clinic" development platform for dry powder inhaler formulations. The company says that as of January 2025, the new platform will halve the time typically required to develop DPI [...]

Read full article »
Annual Revenue
$1.0-5.0B
Employees
10-50K
Andre Lacroix's photo - CEO of Intertek

CEO

Andre Lacroix

CEO Approval Rating

75/100

Read more